Update_Layout 1 - The British Society for Rheumatology
Transcription
Update_Layout 1 - The British Society for Rheumatology
Event update | 1 Your invitation to the UK’s leading rheumatology conference Create your own personalised programme online www.rheumatology.org.uk/programme Event update | 2 Join your colleagues at Rheumatology 2012 | 1-3 May 2012 Invitation We do hope that you are planning to join us at Rheumatology 2012 in Glasgow. The conference is the UK’s leading rheumatology event and offers an invaluable chance for colleagues to come together to learn, network and hear about the latest developments in the field. We are all working in an increasingly challenging environment and so it is more important than ever that we come together as a community to support each other and raise the profile of the specialty. We hope to see you in Glasgow, Prof David L Scott and Mrs Lindsey Hawley What people thought about Rheumatology 2011 96% of delegates would recommend the conference to a colleague 87% say the conference is a key date in their professional calendar 96% of delegates learnt something new 82% of doctors/allied health professionals would change their practice following the conference Register now! www.rheumatology.org.uk/conference | 3 Key information Why should I attend? Rheumatology 2012 is focused on best practice in rheumatology. Sessions are designed with clear aims and outcomes, leading to effective and valuable learning opportunities for the whole rheumatology team. What will I get out of the conference? At the conference you will: Learn about recent developments in the field of rheumatology Explore all aspects of rheumatology including osteoarthritis, osteoporosis, sports medicine, clinical trials, psoriatic arthritis, pain, primary care, work, CTD and basic science Be inspired by keynote lectures, debates, interactive sessions, poster tours, meet the experts and workshops Gain accreditation from the RCP and RCN Network with the whole rheumatology team Learn about the latest research from oral and poster abstracts Meet colleagues from around the world and exchange ideas and advice Gain support for revalidation Discuss commissioning and NHS changes Attend dedicated streams for trainees, allied health professionals and scientists Who should attend? Our varied conference programme appeals to all healthcare professionals with an interest in rheumatology: Consultant rheumatologists Doctors in training Nurse specialists GPs Academics Physiotherapists Researchers Scientists Students Occupational therapists Podiatrists Industry professionals Venue SECC, Exhibition Way Glasgow G3 8YW Rheumatology 2012 will be held at the award winning SECC. This iconic building, symbolising the city of Glasgow and the regeneration of the river Clyde, offers state of the art conference facilities, extensive exhibition space and a four star hotel (the Crowne Plaza) all under one roof. Getting there Steeped in history and shaped by culture and innovation, Glasgow has much to offer delegates, not least its excellent transport links to the rest of the UK and abroad. The closest international airport is just 15 minutes from the city centre and Glasgow Central station offers direct rail connections to many UK cities. For full details of transport options, visit the SECC’s website at www.secc.co.uk/attend.aspx Accommodation Rheumatology 2012 delegates can use the services of our accommodation agent, Reservation Highway, to take advantage of specially negotiated room rates. We have secured an allocation at a variety of hotels across the city, to suit all budgets. Early booking is highly recommended bookings made after 2 April 2012 will be subject to availability and a higher price. Booking can be done online via www.rheumatology.org.uk/accommodation NEW! Create your conference schedule With so many high quality sessions on offer, make sure you make the most of your time at the conference with our online programme planner. View the details of the sessions on offer and build your own conference diary which you can then print off or email. Go to www.rheumatology.org.uk/programme to start planning your time at the UK’s leading rheumatology conference. Early bird registration deadline: Friday 3 February 2012 Event update | 4 Keynote speakers Tuesday 1 May, 14.00 – 16.00 Keynote: Jewels in the crown Sir Philip Craven, President International Paralympic Committee Sir Philip Craven is a five time Paralympian in Wheelchair Basketball (1972-1988) and Swimming (1972). His international achievements in Wheelchair Basketball include World championship/Gold Cup (1973), Gold medal – European Championship (1991 and 1994) and Bronze medal – World Championship/Gold Cup (1975). Sir Philip has also received a number of prestigious awards including Knight Bachelor by HM Queen Elizabeth II for services to Paralympic Sport (2005) and Member of the Order of the British Empire (MBE) by HM Queen Elizabeth II for services to Wheelchair Basketball (1991). Sir Philip is the current President of the International Paralympic Committee. His major contributions to Paralympic sport include Member of the International Olympic Committee (IOC) (since 2003), Member of the Executive Board, British Olympic Association (since 2003), Board Member of the London 2012 Organizing Committee for the Olympic and Paralympic Games (since 2005) and Member of the IOC Commission for Culture and Olympic Education (since 2005). Sir Philip Craven’s professional career has included Performance Director, GBWBA Men’s Wheelchair Basketball Team (1998-2002), Chief Executive Officer, International Wheelchair Basketball Federation (1994-1998) and Company Secretary, British Coal Corporation (Western Area) (1986-1991). Tuesday 1 May, 11.30 – 13.00 Droitwich Lecture Dr Jackie Hill, Senior Lecturer in Rheumatology, University of Leeds, Leeds Jackie has worked in rheumatology for over 30 years as a practitioner, a senior lecturer and a researcher. She was one of the first rheumatology nurses in the UK to hold nurse led clinics and undertook the seminal research into outcomes from these clinics. She obtained her Masters Degree in 1991, her PhD in 2000 and in 1990 was honoured with Fellowship of the Royal College of Nursing for an outstanding contribution to the science and art of rheumatology nursing. Jackie is a former Chair of the RCN Rheumatology Nursing Forum, President of BHPR and has sat on several EULAR committees. More recently she was co-convenor of the EULAR Nursing Task Force which published Recommendations for the Basic and Advanced Role of the Nurse in the Management of Chronic Inflammatory Arthritis. Before her retirement in July 2011 she was co-director of the Academic and Clinical Unit for Musculoskeletal Nursing, a reviewer for ten journals and a grant application reviewer for six national bodies including NIHR. Jackie was the Associate Editor of Musculoskeletal Care and editor/author of three books and ten book chapters. She has published over 130 papers and has given numerous presentations and keynote lectures at national and international conferences. Tuesday 1 May, 16.30 – 17.30 Heberden Round Prof Philip Conaghan, Professor of Musculoskeletal Medicine, University of Leeds, Leeds Professor Conaghan’s major research interests are in understanding pathogenesis and therapeutic response in osteoarthritis and rheumatoid arthritis, with a special focus on the role of imaging. His research incorporates a spectrum from translational and proof-of-concept work through to large clinical trials. He is Professor of Musculoskeletal Medicine at the University of Leeds, and Chairs the NICE OA Guidelines Development Group and Arthritis Research UK’s OA Clinical Studies Group. He previously chaired the Assessment of Structural Change Working Group of the OARSI-FDA OA Initiative. He recently completed his term as inaugural Chair of the EULAR Standing Committee on Imaging, is leader for the OMERACT Imaging & Biomarkers workstream and is President of the International Society for Musculoskeletal Imaging in Rheumatology. He has authored over 250 papers, book chapters and books. Wednesday 2 May 16.45 – 17.45 Heberden Oration Prof Paul Wordsworth, Professor of Rheumatology and Consultant Rheumatologist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford Professor Wordsworth works in the NIHR Oxford Musculoskeletal Biomedical Research Unit. His clinical and research interests are particularly oriented towards understanding the genetic basis of musculoskeletal diseases. These include monogenic disorders, such as Marfan syndrome and skeletal dysplasias, but also complex polygenic inflammatory arthropathies. He is a co-founder of the international consortium investigating the genetics of ankylosing spondylitis that identified the association with IL23R and ERAP1. His group also helped to solve the crystal structure of ERAP1 in 2011. He is co-author of Clinical and Biochemical Disorders of the Skeleton and has published over 300 original scientific papers, mainly on the genetics of rheumatic diseases. He is a Fellow of Green Templeton College. Register now! www.rheumatology.org.uk/conference | 5 Rheumatology 2012 programme Our conference programme is always extremely well evaluated by delegates and we are always striving to deliver high quality content in new and accessible ways. Here are just some of the highlights of this year’s event. Essentials in rheumatology: Our Essentials symposium, now in its third year, has established itself as a valuable feature of the conference. Popular amongst consultants and trainees alike, it serves to support revalidation and draws from the whole rheumatology curriculum over a cycle of five years. This year’s Essentials will explore three broad areas: disease management; symptoms diagnosis; and clinical decision making, with interactive, case-based sessions on ankylosing spondylitis and vasculitis. Allied health professionals: A packed programme. Highlights include a demonstration of the key features of NHS Evidence, an overview of initiatives to reduce work absence for people with musculoskeletal conditions, exploration of the management of inflammatory arthritis and back pain and how therapies can be targeted to improve musculoskeletal pain. There will also be a session providing delegates with indispensable advice on how to get their work accepted as a conference abstract. Pages 15, 19 and 22 Pages 9, 11, 16, 20, 21, 22, 26, 29 and 31 Trainee stream: 2011’s inaugural Rheumatologists at Training symposium was an outstanding success. A dedicated programme for trainees organised by trainees, this year’s symposium will provide updates on the political and the clinical - changes in the NHS and how they affect rheumatology, the clinical teaching of spondyloarthropathies and discussion of the evidence-based approach to myopathies. This symposium is a must for trainees. Primary care: This year’s primary care programme aims to increase communication between hospital rheumatologists and the primary care team. Delegates will explore the difficulties in diagnosing and differentiating between rheumatological conditions and associated problems. In addition to this the role and contribution of allied health professionals working in primary care and the implications of commissioning changes will be explored. Pages 27, 29 and 31 Pages 16, 18, 19, 22 and 23 NHS changes: 2011 was a year of turbulence in the health service for many. We need to revisit the way that we plan and deliver musculoskeletal services in order to demonstrate quality improvement and patient satisfaction. ARMA will be highlighting the changes and innovations that are taking place in England and the devolved nations. Commissioning and the provision of these new services require a new skill set and the trainee and primary care programmes together with the ARMA update will encourage debate and discussion. Sports medicine: London 2012 puts sports medicine firmly on the agenda for our event of the same year. The conference features an overview of the challenges faced by modern sport and exercise medicine practice, highlighting how sports and exercise medicine and rheumatology will be able to interact to provide optimal medical care. In addition to this, our ‘Jewels of the Crown’ session will feature Sir Philip Craven MBE, President of the International Paralympic Committee (IPC) giving a unique keynote address. Pages 16, 19 and 31 Pages 11 and 14 Basic science: Back by popular demand, this year’s science symposium will give attendees an overview and understanding of key issues in the molecular mechanisms of rheumatological pathologies. Current views of osteoarthritis and inflammatory arthritis will be discussed and delegates will be updated on novel laboratory research in each area from both students and experts in the field. Accreditation The RCP have awarded Rheumatology 2012 18 CPD points Pages 26, 29, 31 and 32 Rheumatology 2012 has also been accredited 19 study hours by the Royal College of Nursing Accreditation Unit Event update | 6 Sessions Delegates are free to attend any sessions on the days for which they have registered (subject to room capacity). Tuesday: Session BHPR Oral abstracts Special interest group Keynote session Industry supported symposium Networking event Wednesday: Session Essentials in rheumatology BHPR Oral abstracts Special interest group Keynote session Industry supported symposium Networking event Thursday: Science Trainee Auto immune diseases BHPR Oral abstracts Special interest group Industry supported symposium Note: programme is subject to change at this stage. Tuesday 1 May 2012 09.30 - 10.30 Reproductive issues in rheumatology 8 Clinical trials to advance the development of new therapies 8 Hypermobility - overmedicalised? A debate 8 BHPR: Physical activity and exercise in inflammatory arthritis 9 Oral abstracts: Spondyloarthropathies 9 SIG: BHPR Connective tissue disease SIG: Lung disease in rheumatoid arthritis 9 10 10.30 - 11.30 Poster viewing and exhibition | Tea and coffee 11.30 - 13.00 INBANK, BSR Registers and the new information age 10 Sport and exercise medicine 11 Sex discrimination in the autoimmune rheumatic diseases 11 BHPR: Droitwich Lecture, Lifetime achievement award and Prizes 11 Oral abstracts: Imaging 12 SIG: Polymyalgia rheumatica and giant cell artertis 12 SIG: RA outcomes 13 13.00 - 14.00 Exhibition | Lunch 13.00 - 14.00 BHPR AGM 13 BHPR Post Graduate Research Student Network 13 BSRBR open meeting 13 14.00 - 16.00 Jewels in the Crown 14 16.00 - 16.30 Exhibition | Tea and coffee 16.30 - 17.30 Heberden Round 14 17.30 - 18.00 Industry supported symposia catering 14 18.00 - 19.30 Industry supported symposium: Pfizer Inc 14 19.45 - 21.00 Presidents’ reception 14 Register now! www.rheumatology.org.uk/conference | 7 Wednesday 2 May 2012 07.30 - 09.00 Industry supported symposia: Bristol-Myers Squibb and Cellestis GmbH Thursday 3 May 2012 15 07.30 - 09.00 Industry supported symposium: Abbott 25 SIG: Myositis 25 09.15 - 10.45 Essentials: Disease management 15 09.00 - 10.30 Science: Molecular mechanisms of disease: osteoarthritis 26 Mimickers of myositis and treatment update 16 Optimising therapy for rheumatoid arthritis 26 Osteoporosis: topical issues 16 26 BHPR: Primary care rheumatology: leading the way 16 BHPR: Pain and motor function: mechanisms and treatment approaches Oral abstracts: RA treatments and outcomes 17 Trainee: Interactive quiz and clinical teaching 27 SIG: MSK health in multi ethnic minorities 17 Oral abstracts: Epidemiology 27 SIG: Genetics of inflammatory arthritis 17 SIG: Sjögren’s syndrome 27 SIG: Scleroderma 18 SIG: MSK ultrasound 28 10.30 - 11.30 Poster viewing and exhibition | Tea and coffee 10.45 - 11.45 Poster viewing and exhibition | Tea and coffee 19 11.30 - 13.00 Advances in psoriatic arthritis 28 ARMA: Devolution of health: what can we learn? 19 Science: Molecular mechanisms of disease: inflammatory 29 Rheumatological challenges in primary care 19 Trainee: Ask the experts: myositis 29 BHPR plenary orals 20 arthritis I Oral abstracts: Connective tissue diseases 20 29 SIG: Vasculitis 20 BHPR: The management of upper limb dysfunction in people with rheumatoid arthritis SIG: Paediatric and adolescent rheumatology 21 Oral abstracts: Education 30 SIG: Osteoporosis 30 SIG: Foot and ankle 30 11.45 - 13.15 Essentials: Symptom diagnosis and management 13.00 - 14.00 Exhibition | Lunch 13.15 - 14.45 Exhibition | Lunch 13.15 - 14.45 BSR AGM BHPR: How to get your abstract published 21 21 14.45 - 16.15 Essentials: Keeping up to date, clinical decision making 22 BHPR: Current thinking on conservative management of back pain 22 Juvenile-onset SLE and childhood scleroderma 22 Recent advances in osteoarthritis therapy 22 13.00 - 14.00 Trainee: RATs AGM 31 BHPR: NICE and NHS Evidence and the information revolution 31 14.00 - 15.30 Science: Molecular mechanisms of disease: inflammatory arthritis II 31 Trainee: Rheumatology and the NHS 31 31 BHPR: Improving work participation: new developments in reducing work absence for people with musculoskeletal conditions Oral abstracts: Primary Care 23 23 What’s new in ankylosing spondylitis pathogenesis, assessment and treatment 32 SIG: Heritable disorders of connective tissue SIG: BHPR Rheumatoid arthritis 23 Oral abstracts: Genetics 32 16.15 - 16.45 Exhibition | Tea and coffee 16.45 - 17.45 Heberden Oration 24 17.45 - 18.00 Industry supported symposia catering 24 18.00 - 19.30 Industry supported symposia: Roche and Abbott 24 20.00 - Late Conference dinner and Ceilidh 24 SIG: Education 33 SIG: Osteoarthritis 33 15.00 - 17.00 SIG: Spondyloarthropathy 33 17.00 End of meeting Event update | 8 Tuesday 1 May 2012 Session | BHPR | Oral abstracts | Special interest group | Keynote session | Industry symposium | Networking event 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.20 09.40 10.00 09.00 - 10.30 Aim: Outcome 1: Outcome 2: 09.00 09.25 09.50 10.20 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.20 09.40 10.00 Reproductive issues in rheumatology: do you know how to advise your patients? Chairs: Prof Ian Giles, UCL, London | Prof Caroline Gordon, University of Birmingham, Birmingham To provide delegates with up to date knowledge of the issues surrounding rheumatological conditions and drugs in conception, pregnancy, and lactation Delegates will be aware of the current state of knowledge amongst rheumatologists and obstetricians surrounding the safe use of rheumatological drugs in conception, pregnancy and lactation Delegates will be aware of the need for a national consensus on the use of rheumatological drugs in conception, pregnancy and lactation, and how such a consensus can be achieved Delegates will have a better understanding of the complications in pregnancy associated with rheumatological conditions Is pregnancy a stress test for subsequent development of autoimmunity? Dr David Williams, UCLH, London Drugs in conception, pregnancy, and lactation: towards a national consensus Dr Munther Khamastha, St Thomas’ Hospital, London Are biologics safe in pregnancy? Prof Monika Østensen, Sörlandet Hospital, Kristiansand Rheumatological conditions in pregnancy and the puerperium Prof Catherine Nelson-Piercy, Guy’s and St Thomas’ Hospitals Trust, London Clinical trials to advance the development of new therapies Chair: Dr Duncan Porter, Gartnavel General Hospital, Glasgow This session is to inform rheumatologists about performing clinical trials in rheumatoid arthritis Delegates will understand how stratified medicine and biomarkers can be applied to improve therapeutic responses in patients Delegates will understand the influence of genetics on responses observed in clinical trials Conducting clinical trials in rheumatoid arthritis: practicalities and potential pitfalls Prof Paul Emery, University of Leeds, Leeds Stratified medicine and biomarkers Prof Mahesh Parmar, UCL, London Design, analysis and reporting of pharmacogenetic studies Prof Anne Barton, University of Manchester, Manchester Discussion Hypermobility: overmedicalised? A debate Chairs: Prof Howard Bird | Prof Anthony Redmond, University of Leeds, Leeds To transparently debate key controversial aspects of our diagnosis and management of child and adult joint laxity/hypermobility (as currently defined); this should inform clinical and academic future direction Delegates will gain an understanding of evidence underpinning management and learn new epidemiological data Delegates will Participate in healthy discussion on pros and cons of current diagnosis and management Delegates will decide which of the opposing viewpoints is most convincing First proposition Dr Jacqui Clinch, University of Bath, Bath Second proposition Prof Alan Silman, University of Manchester, Chesterfield First opposition Prof Rodney Grahame, UCL, London Second opposition Dr Alan Hakim, Whipps Cross University Hospital, London Register now! www.rheumatology.org.uk/conference | 9 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.25 09.50 09.00 - 10.30 9.00 9.15 9.30 9.45 10.00 10.15 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.20 09.40 10.00 10.20 Physical activity and exercise in inflammatory arthritis Chairs: Dr Fiona Cramp, University of the West of England, Bristol | Dr Claire Goodchild, King’s College London, London To provide an overview of the role of physical activity and exercise in the management of inflammatory arthritis Attendees will understand the effects of physical activity and exercise in those with inflammatory arthritis Attendees will understand the current UK physical activity guidelines, the uptake and physical activity preferences in people with rheumatic diseases Attendees will consider the implementation of a home based physical activity programme for people with inflammatory arthritis Exercise for rheumatoid arthritis patients Dr Andrew Lemmey, Bangor University, Gwynedd Implementation of a physical activity programme for people with rheumatoid arthritis using motivational interviewing Dr Emalie Hurkmans, Leiden University Medical Centre (LUMC), Leiden, The Netherlands Physical inactivity in rheumatic diseases Ms Victoria Manning, King’s College London, London Oral abstracts: Spondyloarthropathies Detecting axial spondyloarthritis (ASpA) amongst primary care back pain referrals Mrs Claire Harris, Northwick Park Hospital, Harrow Validation of a screening questionnaire for axial SpA in a UK population Dr Karl Gaffney, Norfolk and Norwich University Hospital, Norwich The prevalence and burden of ankylosing spondylitis in Europe: a systematic review Ms Linda Morton, University of Aberdeen, Aberdeen Work disability in established psoriatic arthritis: a cross sectional study using the work productivity activity index (WPAI) Dr Willi Tillett, Royal National Hospital for Rheumatic Diseases, Bath Influence of leflunomide on the levels of matrix metalloproteinase-3 (MMP-3) and pyridinoline (PYR) in patients with psoriatic arthritis (PsA) Dr Dmytro Fedkov, Kiev National Medical, Kyiv, Ukraine Evaluation of efficacy and safety of secukinumab in the treatment of patients with moderate-to-severe ankylosing spondylitis Dr Wolfgang Hueber, Novartis Institutes for BioMedical Research, Basel, Switzerland BHPR SIG: Connective tissue disease To provide an overview of the complexities of disease presentations and management approaches in scleroderma, including digital ulcer disease and pulmonary hypertension To gain an understanding of the diagnostic process for those with scleroderma, including management and treatment options To become aware of the significance of digital ulcer disease in scleroderma, its impact on the patient and the supportive role of the nurse specialist To gain an understanding of the importance of a multi-disciplinary approach in effective and early diagnosis, treatment and management of scleroderma associated lung and cardiac disease Diagnosing scleroderma and treatment options, the role of the rheumatologist Dr John Pauling, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Bath Managing digital ulcers and supporting patients with scleroderma, the role of the clinical nurse specialist Mrs Sue Brown, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Bath Lung and pulmonary vascular disease in scleroderma, the role of the specialist pulmonary physician Dr Jay Suntharalingham, Royal United Hospital, Bath Cardiac and pulmonary vascular disease in scleroderma, the role of the specialist cardiologist Dr Gerry Coghlan, Royal Free Hospital NHS Foundation Trust, London Questions Event update | 10 Tuesday 1 May 2012 Session | BHPR | Oral abstracts | Special interest group | Keynote session | Industry symposium | Networking event 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.30 10.00 10.30 - 11.30 SIG: Lung disease in rheumatoid arthritis To update on progress with the National Database of interstitial lung disease in RA, educate on relationship between pulmonary infection and RA and inform members of the latest data on the effects of anti rheumatic drugs and the lung To ensure that delegates are aware of the national database for ILD in RA and understand how to enter patients into this To educate delegates about the growing body of evidence linking both acute and chronic pulmonary infection with morbidity and mortality in RA To update delegates with the latest data on the effects of the newer biologic agents on the lung in patients with RA The National Database for patients with interstitial lung disease in rheumatoid arthritis: an update Dr Clive Kelly, Queen Elizabeth Hospital, Gateshead The relationship between bronchiectasis, anti CCP antibody and rheumatoid arthritis Dr Elizabeth Perry, Royal Cornwall Hospital, Truro Safety and efficacy of rituximab in patients with rheumatoid arthritis and interstitial lung disease Dr Shouvik Dass, St James Hospital, Leeds Poster viewing and exhibition | Tea and coffee Categories: BHPR Imaging Metabolic and crystal arthropathies Miscellaneous rheumatic diseases Rheumatoid arthritis: clinical features Rheumatoid arthritis: comorbidities Scleroderma and related disorders Spondylarthropathies (including psoriatic arthritis) 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.50 12.10 12.30 12.50 Poster tours: BHPR Rheumatoid arthritis Spondyloarthropathies INBANK, BSR Registers and the new information age Chairs: Prof Deborah Bax, Royal Hallamshire Hospital, Sheffield | Prof David L Scott, King’s College London, London To inform the membership about new and emerging data resources in rheumatology, and to raise awareness of the opportunities afforded by the establishment of INBANK as a national resource for clinical data linkage to biological samples and NHS outcomes Understand the value of national data resources in rheumatology and raise awareness of datasets including the newly established ankylosing spondylitis biologics register and the national joint register Understand how INBANK will function and allow clinicians both to audit their own clinical performance Allow participants to ask questions about key issues including consent, access, security and resources Advances in drug information in rheumatic disease: the ankylosing spondylitis register Prof Gary Macfarlane, University of Aberdeen, Aberdeen The power of data linkage: lessons from the National Joint Register Prof Alex MacGregor, University of East Anglia, Norwich INBANK: a national musculoskeletal information platform Prof Alan Silman, Arthritis Research UK, Chesterfield INBANK in practice Dr William Dixon, University of Manchester, Manchester Discussion Register now! www.rheumatology.org.uk/conference | 11 11.30 - 13.00 Sport and exercise medicine Chairs: Prof Nicola Maffulli, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London | Dr Roger Wolman, Royal National Orthopaedic Hospital, London Aim: Outcome 1: To provide delegates an overview of the challenges faced by modern sport and exercise medicine practice Delegates will be able to identify the key issues concerning modern sport and exercise medicine practice, and discuss these in an open, interactive session Delegates will be aware of how these issues may affect rheumatology in the future Delegates will have a better understanding of how sports and exercise medicine and rheumatology will be able to interact to provide optimal medical care Outcome 2: Outcome 3: 11.30 11.35 11.55 12.15 12.40 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.55 12.10 12.25 12.40 11.30 - 13.00 11.30 12.15 12.20 British sport and exercise medicine: a five minute history of a specialty Prof Nicola Maffulli, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London Exercise: a unique therapeutic intervention for primary, secondary and tertiary disease prevention. Let’s all prescribe it! Dr Christopher Hughes, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London Anterior cruciate ligament reconstruction: good for your knee? Prof Anthony Bull, Imperial College London, London Platelet-rich plasma in musculoskeletal medicine: some truths Dr Umile Giuseppe Longo, University Campus Biomedico, Rome, Italy Taking care of tender tendons Prof Nicola Maffulli, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London Why can’t a man be more like a woman? Sex discrimination in autoimmune rheumatic diseases Chairs: Prof David Isenberg, University College London Hospital, London | Dr Patrick Gordon, King’s College Hospital, London To provide a thought provoking session on the evident disparity in the prevalence, causes and consequences of autoimmune rheumatic disease (ARDs) involvement between men and women To achieve a better understanding of the disparity and differential effects of ARDs on men and women To achieve a better understanding of the links between the immune and endocrine systems To achieve a better understanding of whether hormonal manipulation might play a part in the therapy of ARDs Endocrine influences on the immune system Dr Betty Diamond, Feinstein Institute Medical Research, New York, USA Male lupus: the Loch Ness monster syndrome revisited Prof David Isenberg, University College London Hospital, London Rheumatoid arthritis in men Prof John Isaacs, University of Newcastle, Newcastle Upon Tyne Scleroderma in men Prof Christopher Denton, Royal Free Hospital, London Blocking female hormones: smart or stupid? Prof Anisur Rahman, University College London Hospital, London Droitwich Lecture, Lifetime achievement award and Prizes Chair: Mrs Lindsey Hawley, President BHPR Rheumatology nursing: a journey of discovery Dr Jackie Hill, Senior Lecturer in Rheumatology Nursing, University of Leeds, Leeds Lifetime achievement award Dr Jackie Hill, Senior Lecturer in Rheumatology Nursing, University of Leeds, Leeds Prize ceremony Event update | 12 Tuesday 1 May 2012 Session | BHPR | Oral abstracts | Special interest group | Keynote session | Industry symposium | Networking event 11.30 - 13.00 11.30 11.45 12.00 12.15 12.30 12.45 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.45 12.00 12.15 12.30 12.45 Oral abstracts: Imaging Hand osteoarthritis pain has peripheral and central components demonstrated by algometer scores and functional MRI Dr Nidhi Sofat, St George’s, University of London, London Ultrasound features of osteophytes and cartilage thickness at the knee are associated with pain and functional impairment: the Newcastle thousand families study Dr Ajay Abrah, Newcastle University, Newcastle upon Tyne The diagnostic utility of salivary gland ultrasound for the investigation of sjögren’s syndrome Dr Andrew Carr, Newcastle Dental Hospital, Newcastle upon Tyne Long-term radiographic outcome in psoriatic arthritis patients treated with Golimumab: 104 week results from the go-reveal study Dr Chandrabhusan Chattopadhyay, Wrightington Hospital, Wigan Early effect of Secukinumab in reducing spinal inflammation as detected by magnetic resonance imaging in patients with ankylosing spondylitis Prof Jaap Van Laar, Newcastle University, Newcastle upon Tyne Tocilizumab as monotherapy or in combination with methotrexate associated with early reductions in tissue inflammation: 12 week results from a magnetic resonance imaging substudy of a randomized controlled trial Prof Philip Conaghan, University of Leeds, Leeds SIG: Polymyalgia rheumatica and giant cell artertis To increase awareness of the attendees of advances in the diagnosis, guidelines on management, clinical trials, biomarkers and patient support in PMR and GCA Attendees will learn about the EULAR ACR Classification Criteria for PMR and the approach to differentiate PMR from other conditions that present with a polymyalgic syndrome Attendees will learn about the management of PMR and GCA in PMR and development of pathways to improve diagnosis and reduce ischemic complications Attendees will learn about the status of ongoing clinical trials in PMR, GCA and large vessel vasculitis PMR Classification Criteria Prof Bhaskar Dasgupta, Southend University Hospital, Southend Pathways and management of PMR and GCA in primary care Prof Christian Mallen, Keele University, Keele Clinical trials in PMR, GCA and large vessel vasculitis Prof Carlo Salvarani, Azienda Ospedaliera Arcispedale Santa Maria Nuova Reggio Emilia, Italy Annexin and its receptor in PMR and GCA Prof Mauro Perretti, St Barts Hospital, London Development of a patient support organisation for PMR and GCA Dr Kate Gilbert, Chair, PMRGCAUK Discussion Register now! www.rheumatology.org.uk/conference | 13 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.50 12.10 12.30 12.50 SIG: RA outcomes To discuss topical & recent issues in management & outcomes of early RA by leaders in this field Understand the many facets of pain in RA Appreciate the importance of joint failure in RA as measured by orthopaedic surgery Debate the different perspectives proposed for DAS28 cut offs for biological therapy Pain in early RA: inflammatory or central sensitisation? Prof David Walsh, The University of Nottingham, Nottingham Orthopaedic interventions for RA: clinical and health economic aspects Dr Elena Nikiphorou, Norfolk and Norwich University Hospital, Norwich and Prof Steve Morris, UCL, London DAS28 criteria for initiation of biologics in early RA: a clinician’s view Dr Patrick Kiely, St George’s Hospital, London DAS28 criteria for initiation of biologics in early RA: NICE perspectives Dr Chris Deighton, Derby Hospitals NHS Trust, Derby Discussion 13.00 - 14.00 Exhibition | Lunch 13.00 - 14.00 BHPR AGM Join your colleagues over lunch and meet BHPR Council members to hear what they have been doing on your behalf and how they plan to meet the challenges of the year ahead. Your attendance, which is highly valued, automatically enters you into the prize draw for a chance to win free registration to the 2013 conference in Birmingham. 13.00 - 14.00 BSRBR open meeting 13.00 - 14.00 BHPR Post Graduate Research Student Network: a practical guide to post-doctoral career progression Chairs: Dr Michael Backhouse, University of Leeds, Leeds | Ms Lindsay Hooper, University of Southampton, Southampton Aim: Outcome 1: Outcome 2: Outcome 3: 13.00 13.05 13.25 To provide a coordinated network for early career researchers that facilitates peer group discussion and support from a range of leading academics Attendees will be able to identify the key steps in developing post-doctoral careers Attendees will gain practical tips on developing collaborative networks, managing funding portfolios and structuring programs of research Attendees will have the opportunity to discuss the lecture content with peers and senior academics, facilitating the opportunity to develop their own collaborative links Introduction from the chair Dr Michael Backhouse, Leeds Musculoskeletal Biomedical Research Unit, Leeds Post-PhD career planning Prof Nadine Foster, Keele University, Keele Facilitated group discussion Prof Sarah Hewlett and Dr Tessa Sanderson, University of West of England, Bristol Event update | 14 Tuesday 1 May 2012 Session | BHPR | Oral abstracts | Special interest group | Keynote session | Industry symposium | Networking event 14.00 - 16.00 14.00 14.20 14.40 15.00 15.20 15:40 Jewels in the crown Chairs: Prof David L Scott, President BSR | Mrs Lindsey Hawley, President BHPR London 2012 Olympic Games: keynote lecture Sir Phillip Craven MBE, President of the International Paralympic Committee (IPC) Michael Mason prize winner: Silver standard: measuring treatment effects using observational data Dr Kimme Hyrich, University of Manchester, Manchester Garrod Prize winner: The relationship between pregnancy and long-term functional disability in women with inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR) Mrs Elizabeth Camacho, University of Manchester, Manchester Epidemiology of sporting injuries on elite soccer players: a longitudinal study Mr Philip Cooper, MRC Lifecourse Epidemiology Unit, Southampton Epratuzumab demonstrates clinically meaningful improvements in patients with moderate to severe systemic lupus erythematosus (SLE): results from Emblem™, a phase IIB study Prof Caroline Gordon, University of Birmingham, Birmingham Will I waste your time? Delays in help-seeking for RA flares Ms Caroline Flurey, University of the West of England, Bristol 16.00 - 16.30 Exhibition | Tea and coffee 16.30 - 17.30 Heberden Round: The new rheumatoid arthritis Prof Philip Conaghan, Chair of Musculoskeletal Medicine, University of Leeds, Leeds 17.30 - 18.00 Industry supported symposia catering 18.00 - 19.30 Industry supported symposia: Pfizer 19.45 - 21.00 Presidents’ reception The Presidents of BSR and BHPR invite you to join them at this dedicated networking event at the nearby Crowne Plaza hotel which will provide the perfect opportunity to meet and continue your discussions with rheumatology colleagues and industry peers in a relaxed and informal setting. Drinks and canapés will be provided | This event is free to attend for registered delegates Register now! www.rheumatology.org.uk/conference | 15 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 07.30 - 09.00 Industry supported symposia: Cellestis GmbH Bristol-Myers Squibb Getting it right: optimising RA treatment strategies in the evolving NHS Chair: Prof Philip Conaghan, University of Leeds, Leeds Aim: Outcome 1: Outcome 2: Outcome 3: Conclusion: 09.15 - 10.45 Aim: Outcome: 09.15 09.45 10.15 To educate delegates on how they can tailor biologic treatment choices in rheumatoid arthritis (RA) to deliver value both for patients and the NHS, in context of the evolving NHS (QIPP, QoF). To deliver an update on the differing mode of actions of biologic therapy, examining whether the different MOA’s available offer different outcomes for patients. The session will also explore the current theories/research into the RA patient profiling, and show how tailoring biologic therapy can offer better outcomes for the patient whilst delivering value to the NHS Delegates will have a better understanding of how the NHS changes (White Paper, QIPP agenda) could affect the role of the rheumatologist and specialist RA services. Highlighting the need for services to be able to demonstrate the best outcomes for patients, whilst driving efficiencies Delegates will have an update into the current research that is taking place into patient profiles/subtypes in RA and how these can be used to deliver better outcomes Delegates will understand how using a tailored approach to biologic therapy can improve patient outcomes/demonstrate value to the NHS, within the framework of currently available NICE guidance The new NHS and rheumatology: what does the future hold? Dr Mark Davies, RES Consortium and Dr P Kiely, St George’s Healthcare NHS Trust, London Is MOA of biologics important when choosing an RA treatment? Prof Iain McInnes and Prof Paul Garside, University of Glasgow, Glasgow Patient profiling in RA: what do we know? Where are we heading? Dr Andrew Östör, Addenbrooke’s Hospital, Cambridge Tailoring biologic treatment to patient profiles in RA Dr Josef S Smolen, University of Vienna, Vienna, Austria To conclude the meeting there will be closing remarks from the Chairperson, followed by a panel Q&A to draw conclusions on the session as a whole Essentials in Rheumatology: Disease management Chairs: Prof John Axford, St George’s Hospital, London | Dr Charles Mackworth-Young, Charing Cross Hospital, London A comprehensive update covering everything you need to know about changes in rheumatology To prepare rheumatologists for revalidation and provide a valuable educational opportunity for trainees Delegates will have been brought up to date on disease management Metabolic bone diseases Prof Juliet Compston, University of Cambridge, Cambridge Psoriatic arthritis Prof Oliver Fitzgerald, St Vincent’s University Hospital, Dublin Antiphosphlipid syndrome Prof Anisur Rahman, UCL, London Event update | 16 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 09.15 - 10.45 Aim: Outcome 1: Outcome 2: Outcome 3: 09.15 09.45 10.15 09.15 - 10.45 Aim: Outcome 1: Outcome 2: Outcome 3: 09.15 09.40 10.05 10.30 09.15 - 10.45 Outcome 1: Outcome 2: Outcome 3: 09.15 09:40 10.05 10.30 Mimickers of myositis and treatment update: room for improvement and lessons from neurology Chair: Dr Robert Cooper, Hope Hospital, Manchester To provide delegates with an overview of the issues surrounding misdiagnosis in myositis and an update in best practice Delegates will be able to identify the key factors in securing a diagnosis of metabolic/mitochondrial myopathy or dystrophy and excluding inflammatory myopathy Delegates will have a better understanding of the key clinical features in inclusion body myositis, how the diagnosis may be missed and current management strategies Delegates will receive an update on current best practice in the management of myositis Adult onset metabolic/mitochondrial myopathies and dystrophies: how these cases can be missed Dr Mark Roberts, Salford Royal NHS Foundation Trust, Salford Inclusion body myositis and misdiagnosis of polymyositis Prof Michael Hanna, National Hospital for Neurology and Neurosurgery, London (to be confirmed) Treatment update and best practice in inflammatory myopathy Prof Chester Oddis, Arthritis Institute, Pittsburgh, USA Osteoporosis: topical issues Chair: Dr Emma Clark, University of Bristol, Bristol To provide general rheumatologists and trainees with an update on topical issues in osteoporosis To understand the association between calcium/vitamin D supplementation and cardiovascular outcomes To discuss ways of maximising adherence with bisphosphonates To highlight how recent advances in genetics of High Bone Mass could impact on clinical practice Should we stop regular prescribing of calcium/vitamin D supplementation because of the risk of adverse cardiovascular outcomes? Prof Bo Abrahamsen, University of Southern Denmark, Odense, Denmark Bisphosphonates: what can we do to maximise adherence? Prof Rob Horne, University of London, London Applying recent insights in causes of High Bone Mass to clinical practice Dr Celia Gregson, University of Bristol, Bristol Discussion Primary care rheumatology: leading the way Chairs: Dr Louise Warburton, NHS Telford and Wrekin, Telford | Ms Melanie Holden, Keele University, Keele Delegates will gain an understanding of models of established primary care based musculoskeletal services Delegates will have an awareness of the role and contribution of allied health professionals working in primary care Delegates will explore the implications of commissioning changes for allied health professionals Primary care led rheumatology services Dr Jill Firth, Pennine Musculoskeletal Partnership, Oldham Musculoskeletal interface clinics: how physiotherapy has contributed to this model of care Mrs Kay Stevenson, Haywood Hospital, Stoke on Trent Business planning for a patient centred rheumatology service Mrs Ann Todd, Pennine Musculoskeletal Partnership, Oldham Discussion Register now! www.rheumatology.org.uk/conference | 17 09.15 - 10.45 9.15 9.30 9.45 10.00 10.15 10.30 09.15 - 10.45 Aim: Outcome 1: Outcome 2: Outcome 3: 09.15 09.45 10.15 09.15 - 10.45 Aim: Outcome 1: Outcome 2: Outcome 3: 09.15 09.35 09.55 10.15 10.35 Oral abstracts: RA treatment and outcomes Validation of JADAS in all subtypes of juvenile idiopathic arthritis (JIA) in the clinical setting Dr Flora McErlane, University of Manchester, Manchester Has orthopaedic intervention for RA changed in line with combination and anti-TNF therapies? An evaluation of joint surgery rates and prognostic factors in two UK inception cohorts (1986-2011) ERAS/ERAN Dr Elena Nikiphorou, St Albans City Hospital, St Albans Predicting responses to anti-TNFα therapy in patients with rheumatoid arthritis using metabolomic analysis of urine Dr Sabrina Kapoor, University of Birmingham and Sandwell and West Birmingham Hospitals NHS Trust, Birmingham Doubleblind study of Tocilizumab + Methotrexate vs Tocilizumab + placebo in patients with active rheumatoid arthritis despite prior Methotrexate: progression of structural dage, quality of life, and physical function at 24 weeks Prof Maxime Dougados, Paris-Descartes University, Cochin Hospital, Paris, France Secukinumab treatment provides sustained response over one year in patients with rheumatoid arthritis Dr Patrick Durez, Université Catholique de Louvain, Louvain, Belgium Withdrawal of Adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with Adalimumab plus Methotrexate: results of a phase 4, double-blind, placebo-controlled trial Prof Paul Emery, Leeds Teaching Hospital, Leeds SIG: MSK health in multi ethnic minorities To develop awareness of health issues in multi ethnic minorities with special emphasis on MSK health To understand the global issues on multi ethnic minority health issues To develop programmes of research and audit To develop strategy of improving the health care with special emphasis on MSK health Global health issues in multi ethnic minority: UK perspective Dr Sonya Fernandez, Kent University, Canterbury What research should be done in minority communities and how to publish Dr Kamran Abbasi, The Royal Society of Medicine, London Taking patient education into newer immigrant communities Ms Chandrika Gordhan, University of Birmingham, Birmingham SIG: Genetics of inflammatory arthritis To illustrate how advances in the understanding of the genetic basis of rheumatic diseases may impact clinically The attendees will understand the role of genetic markers in risk prediction and how this is being applied in the clinical setting Delegates will appreciate that treatment response is multi-factorial and will understand that genetics, environmental, host factors and epigenetics all play a role Novel approaches to analysis of outcome will be described with reference to juvenile idiopathic arthritis Using genetics to inform risk prediction in RA Dr Sophia Steer, King’s College Hospital, London Predicting treatment response Prof Anne Barton, The University of Manchester, Manchester The role of epigenetics in prediction of treatment response Prof Gerry Wilson, The University of Sheffield, Sheffield Translation of genetic studies into prediction of outcome in JIA Prof Wendy Thomson, The University of Manchester, Manchester Panel discussion Event update | 18 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 09.15 - 10.45 Aim: Outcome 1: Outcome 2: Outcome 3: 09.15 09.30 09.45 10.00 10.15 10.30 10.45 - 11.45 SIG: Scleroderma To discuss some of the challenging areas of management of systemic sclerosis and present consensus best practice pathways that have been developed over the past 18 months by scleroderma centres in the UK. This is a major initiative of the UK scleroderma study group (UKSSG) that has developed draft consensus pathways for digital vasculopathy and for gastrointestinal complications of scleroderma (systemic sclerosis). Appreciation of multi-disciplinary definition of the domains of major clinical involvement of the gastrointestinal tract in scleroderma. Understanding the interplay between upper and lower limb vasculopathy leading to complications of secondary Raynaud’s phenomenon in scleroderma. Challenges in early detection of systemic sclerosis and appropriate stratification of cases for high intensity treatment such as immunosuppression with stem cell rescue Development of expert consensus best practice management for systemic sclerosis: a UK scleroderma study group (UKSSG) initiative Prof Chris Denton, UCL Medical School/Royal Free Hospital, London Gastrointestinal tract manifestations of systemic sclerosis Dr Charles Murray, Royal Free Hospital, London Complications of scleroderma vasculopathy: Raynaud’s phenomenon, digital ulcers and critical digital ischaemia Prof Ariane Herrick, Salford Royal Hospital and University of Manchester, Manchester Impact of high intensity immunosuppression on vasculopathy and gastrointestinal tract disease in systemic sclerosis - is global disease modification possible? Dr Madolon Vonk, Nijmegen University Medical Centre, Nijmegen, Netherlands Early diagnosis of scleroderma: prevention rather than treatment. Secondary Raynaud’s and risk stratification by autoantibody profile Prof Neil McHugh, Royal National Hospital for Rheumatic Diseases, Bath Discussion Poster viewing and exhibition | Tea and coffee Categories: Poster tours: Muscle disorders Osteoarthritis Orthopaedics and rehabilitation Rheumatoid arthritis: treatment Osteoarthritis Osteoporosis and metabolic bone disease Paediatric and adolescent rheumatology Primary care Psychology, measurement and management of pain Rheumatoid arthritis: treatment Soft tissue and regional musculoskeletal disease, fibromyalgia Register now! www.rheumatology.org.uk/conference | 19 11.45 - 13.15 11.45 12.15 12.45 11.45 - 13.15 Aim: Outcome 1: Outcome 2: Outcome 3: Outcome 4: 11.45 12.00 12.25 12.50 11.45 - 13.15 Aim: Outcome: 11.45 12:15 12.45 ARMA session Devolution of health: what can we learn? Chair: Prof David Marsh, UCL, London Focus on Scotland Dr Sarah Mitchell, National Programme Manager for the Delivery Framework for Adult Rehabilitation, Greater Glasgow and Clyde This project has three key work areas: 1) Multi professional MSK care pathways 2) A pilot using NHS 24 telephony to provide a national advice triage service to signpost to information and local MSK services 3) Embedding working health services Scotland in all MSK pathways Focus on England: Taking forward the MSK networks and an update on commissioning activity Prof David Marsh, UCL, London and Mrs Laura Guest, CEO British Society for Rheumatology Focus on Wales Speaker to be confirmed Rheumatological challenges in primary care Chair: Dr Elspeth Wise, Encompass Healthcare, Washington To provide delegates with an understanding of difficulties in diagnosing rheumatological conditions and associated problems in primary care Awareness of how frequently rheumatological problems present in primary care Understanding of how to diagnose early inflammatory arthritis in primary care Increased knowledge of co-morbidity associated with polymyalgia rheumatica Understanding of how to differentiate inflammatory back pain from other causes of low back pain in primary care What musculoskeletal problems does the average GP see? Dr Mark Porcheret, Arthritis Research UK Primary Care Centre, Keele How to better diagnose early inflammatory arthritis in primary care Dr Karim Raza, University of Birmingham, Birmingham Polymyalgia rheumatica: more than just shoulder pain Prof Christian Mallen, Arthritis Research UK Primary Care Centre, Keele Seeing the wood for the trees: diagnosing inflammatory back pain in primary care Prof Ingemar Petersson, Skane University Hospital, Lund, Sweden Essentials in rheumatology: symptom diagnosis and management Chairs: Prof John Axford, St George’s Hospital, London | Dr Charles Mackworth-Young, Charing Cross Hospital, London A comprehensive update covering everything you need to know about changes in rheumatology To prepare rheumatologists for revalidation and provide a valuable educational opportunity for trainees Delegates will have had the opportunity to discuss symptom diagnosis Ocular manifestations of rheumatological disorders Mr Carlos Pavesio, Moorfields Eye Hospital, London Is there infection? Arthritis, bones and prosthetics Prof Tony Berendt, Nuffield Orthopaedic Centre, Oxford Improving patient management: what do patients want? Prof Sir Gordon Duff, University of Sheffield, Sheffield Event update | 20 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 11.45 - 13.15 11.45 12.00 12.15 12.30 12.45 13.00 11.45 - 13.15 11.45 12.00 12.15 12.30 12.45 13:00 11.45 - 13.15 Aim: Outcome 1: Outcome 2: Outcome 3: BHPR plenary orals The impact of pain on successful ageing Dr Ross Wilkie, Keele University, Keele Forefoot bursae are a prognostic indicator of disabling foot complications in patients with RA: results of a prospective three-year study Ms Lindsey Hooper, University of Southhampton, Southampton The continuing professional development for health professionals working within musculoskeletal services: a national UK survey Dr Jo Adams, University of Southampton, Southampton Debridement of painful forefoot plantar callosities in rheumatoid arthritis: the CARROT randomised controlled trial Mrs Heidi Siddle, University of Leeds, Leeds Psychological well-being in early rheumatoid arthritis: findings from the early rheumatoid arthritis network (ERAN) Dr S Norton, University of Cambridge, Cambridge Health professionals’ perceptions of the effects of exercise on joint health in rheumatoid arthritis (RA) patients II: a follow-up focus group study Ms Serena Halls, Bangor University, Cardiff Oral abstracts: Connective Tissue Diseases Variability in the phenotype of metabolic syndrome over time in a multicentre international inception cohort of patients with SLE Dr Ben Parker, University of Manchester, Manchester Nitrated nucleosome levels in patients with systemic lupus erythematosus: associations with ethnicity, autoantibody status and disease activity Dr Sara Croca, University College London, London Is there an association between Warfarin and survival in SSC-PAH patients treated with first line bosentan monotherapy? Dr Clare Warrell, Royal Free Hampstead NHS Trust, London ANTI-EIF2 is associated with interstitial lung disease in patients with systemic sclerosis Dr Zoe Betteridge, Royal National Hospital for Rheumatic Diseases, Bath Optical coherence tomography validation: a new quantitative imaging biomarker for affected skin in scleroderma Dr Giuseppina Abignano, Leeds Institute of Molecular Medicine, Leeds The clinical relevance of ANTI-RO52 and ANTI-RO60 in patients in the United Kingdom primary sjögren’s syndrome registry (UKPSSR) Dr Josephine Vila, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Sunderland SIG: Vasculitis To provide an update on current areas of research in systemic vasculitis, emphasising the potential for attendees to take an active role To gain an understanding of the diverse research projects curently conducted in systemic vasculitis To understand the evidence base for current management in systemic vasculitis (including emerging diagnostic tests and therapeutics) To enable attendees to take an active role in vasculitis studies now and in the future Register now! www.rheumatology.org.uk/conference | 21 11.45 12.00 12.15 12.30 12.45 13.00 11.45 - 13.15 Aim: Outcome 1: Outcome 2: Outcome 3: 11.45 12.05 12.25 12.45 13.05 Quality of life in ANCA associated vasculitis (VASQoL study findings) Dr Neil Basu, University of Aberdeen, Aberdeen Update on developing diagnostic and classification criteria in systemic vasculitis (DCVAS)/ Update on the temporal artery biopsy vs ultrasound study (TABUL) Dr Joanna Robson and Prof Raashid Luqmani, University of Oxford, Oxford Use of the General Practice Research database in vasculitis: focus on aortic aneurysm risk in GCA Prof Nigel Arden, University of Oxford, Oxford European Vasculitis Study Group (EUVAS) therapeutic trials in vasculitis where have we got to and where are we going? Dr David Jayne, Addenbrooke’s Hospital, Cambridge, Genome wide association studies in ANCA associated vasculitis Dr Richard Watts, University of East Anglia, Ipswich Panel discussion SIG: Paediatric and adolescent rheumatology To focus on the changing role of paediatric and adult rheumatologists in the care of young people, including discussion of the drivers and barriers for change and consumer involvement Delegates will have discussed how we ensure adult services provide rheumatologists with appropriate skills and experience to take on the care of young people Delegates will have addressed how we engage young people / consumers in their care and involving them in research Delegates will have fedback on what they would like the paediatric and adolescent SIG to achieve in the future Standards of care for children and young people with JIA Dr Eileen Baildam, Alder Hey Hospital, Liverpool Changing role of adult rheumatologists in paediatric and adolescent care Prof Helen Foster, Newcastle University, Newcastle upon Tyne Adolescent training Issues and RCP involvement Dr Rachel Tatterall, Sheffield Teaching Hospitals NHS Trust, Sheffield Involving young people in rheumatology research Dr Janet McDonagh, Birmingham Children’s Hospital, Birmingham Discussion 13.15 - 14.45 Exhibition | Lunch 13.15 - 14.45 BSR AGM Join your colleagues over lunch and meet the Trustees and committee members of your society. Hear what they have been doing on your behalf and how they plan to meet the challenges of the year ahead. Your attendance is highly valued and lunch will be provided 13.15 - 14.45 How to get your abstract published Chair: Ms Tricia Cornell, Poole Hospital NHS Foundation Trust, Poole Aim: Outcome 1: Outcome 2: Outcome 3: 13.15 13.35 To provide delegates with the tools to submit a quality abstract submission Delegates will understand the key issues surrounding a quality abstract submission Delegates will be able to critically analyse an abstract submission with a view to improving the quality Delegates will be able to re-formulate an abstract to make a quality submission Abstract review: what the reviewers are looking for in a quality abstract submission Ms Tricia Cornell, Poole Hospital NHS Foundation Trust, Poole Group work: Critically analyzing 2-3 abstracts Ms Tricia Cornell, Poole Hospital NHS Foundation Trust, Poole | Ms Diana Finney, Sussex Community NHS Trust, Brighton | Dr Sarah Ryan, Haywood Hospital, Stoke on Trent Event update | 22 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 14.45 - 16.15 Aim: Outcome 1: Outcome 2: Outcome 3: 14.45 15.05 15.25 15:45 Current thinking on conservative management of back pain Chairs: Mrs Sue Gurden, Aneurin Bevan Health Board, Abergavenny | Prof Nadine Foster, Keele University, Keele To update delegates on current thinking on low back pain management Delegates will have an increased knowledge of tools available to aid treatment selection in low back pain in the clinic Delegates will have an increased knowledge of health economics and it’s clinical application in treatment selection and service delivery in low back pain Delegates will have an increased knowledge of the influence of patient’s and practitioner’s health beliefs on rehabilitation in low back pain Can we choose the best treatment for back pain patients? Dr Jonathan Hill, Keele University, Keele Are back pain treatments cost-effective? What clinicians need to know about health economics Dr Duncan Critchley, King’s College London, London Low back pain in primary care Prof Martin Underwood, University of Warwick, Coventry The direct and indirect impact of health beliefs in low back pain on outcomes Dr Tamar Pincus, University of London, Egham 14.45 - 16.15 Essentials in rheumatology: Keeping up to date, clinical decision making - what is the evidence? Chairs: Prof John Axford, St George’s Hospital, London | Dr Charles Mackworth-Young, Charing Cross Hospital, London Put your clinical decision making to the test using interactive voting keypads Aim: Outcome: To prepare rheumatologists for revalidation and provide a valuable educational opportunity for trainees Delegates will have had their clinical decision making skills tested 14.45 15.30 14.45 - 16.15 14.45 15:10 15.35 16.00 14.45 - 16.15 Aim: Outcome 1: Outcome 2: Outcome 3: Ankylosing spondylitis Prof Roger Sturrock, Glasgow Royal Infirmary, Glasgow Vasculitis Dr David Jayne, University of Cambridge, Cambridge Juvenile-onset SLE and childhood scleroderma: new insights into pathology, treatment and outcomes Chairs: Dr Jacqui Clinch, University of Bath, Bath | Prof David Isenberg, UCL, London What is the natural history of scleroderma with its onset in childhood? Dr Eileen Baildam, Alder Hey Children’s NHS Foundation Trust, Liverpool Why is it important to know about lupus in children? Prof Michael Beresford, Alder Hey Children’s Foundation NHS Trust, Liverpool Improving and optimising long term outcomes of patients with juvenile-onset SLE Dr Clarissa Pilkington, Great Ormond Street Hospital, London Panel discussion Recent advances in osteoarthritis therapy Chairs: Prof Philip Conaghan, University of Leeds | Dr George Peat, Keele University, Keele To provide delegates with a state of the art update on the clinical management and structural modification of OA Understand the varying effectiveness of mechanical interventions in the clinical management and structural modification of lower limb OA Understand the therapeutic role and effectiveness of structural modifying drugs in OA Gain understanding of joint distraction as a method of tissue modification in OA Register now! www.rheumatology.org.uk/conference | 23 14.45 15.05 15.25 15.45 14.45 - 16.15 14.45 15.00 15.15 15.30 15.45 14.45 - 16.15 Aim: Outcome 1: Outcome 2: Outcome 3: 14.45 15.05 15.25 15.45 16.05 14.45 - 16.15 Aim: Outcome 1: Outcome 2: Outcome 3: Mechanical effectiveness of foot orthoses in OA Mrs Jill Halstead, University of Leeds, Leeds Varying effectiveness of mechanical interventions in knee OA Dr Richard Jones, University of Salford, Salford Tissue structure modification in late stage osteoarthritis is feasible Prof Floris Lafeber, University Medical Center Utrecht, Utrecht, The Netherlands Lecture to be confirmed Oral abstracts: Primary Care Audit to assess GP awareness and documentation of biologic and DMARD drugs in primary care patient records Dr Charlotte Goodhead, Queen Elizabeth Hospital Gateshead, Gateshead The MRC physiodirect trial: a pragmatic randomised controlled trial of ‘physiodirect’ telephone assessment and advice services versus usual care for musculoskeletal problems Dr Annette Bishop, Keele University, Keele Frequency of musculoskeletal symptoms and presenting complaints in video observed primary care consultations with patients aged 45 and over Dr Zoe Paskins, Arthritis Research UK Primary Care Centre, Keele Deciding to consult the general practitioner for symptomatic osteoarthritis: a choice-based conjoint analysis study Ms Domenica Coxon, Keele University, Keele Are rheumatoid arthritis patients screened for cardiovascular disease in primary care? Ms Helen Monk, Keele University, Keele SIG: Heritable disorders of connective tissue Chair: Prof Howard Bird, University of Leeds, Leeds To equip rheumatology clinicians with knowledge and understanding of the impact of chronic pain in EDS/JHS and the evidence base for its alleviation by physical and cognitive interventions Delegates will acquire a greater appreciation of the multi-systemic nature of EDS/JHS, including chronic pain, dysautonomia and gastrointestinal dysmotility Delegates will be able to offer a multidisciplinary strategy for the rehabilitation of patients with severe deconditioning, reduced mobility and independence Delegates will acquire a greater familiarity with new developments in relevant therapeutic modalities in the published literature Hypermobility, fibromyalgia and chronic pain Dr Alan Hakim, Whipps Cross Hospital, London Medical rehabilitation and pain control Dr Helen Cohen, Royal National Orthopaedic Hospital, Stanmore Physical rehabilitation: role of physiotherapy/OT Rosemary Keer, Hospital of St John and St Elizabeth's, London Cognitive interventions in EDS/JHS and chronic pain Dr Clare Daniel, UCLH, London Panel discussion BHPR SIG: Rheumatoid arthritis To hold a session on rheumatoid arthritis of interest to BHPR and BSR members. Topics to be covered are tocilizumab therapy and early arthritis Delegates will learn new information on tocilizumab therapy Delegates will learn about the delays to presentation and treatment in RA Delegates will have an opportunity to ask questions and participate in discussion on the topics presented Programme to be confirmed 16.15 - 16.45 Exhibition | Tea and coffee Event update | 24 Wednesday 2 May 2012 Session | Essentials in rheumatology | BHPR | Oral abstracts | Special interest group | Keynote session Industry supported symposium | Networking event 16.45 - 17.45 Heberden Oration Lessons in rheumatology from extreme phenotypes and subtle genotypes Prof Paul Wordsworth, Professor of Rheumatology and Consultant Rheumatologist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences 17.45 - 18.00 Industry supported symposia catering 18.00 - 19.30 Industry supported symposia: Abbott The patient at the heart of Treat to Target New practical tools to optimise the consultation process Chair: Prof Paul Emery, Chapel Allerton Hospital, Leeds 18.00 18.05 18.20 18.50 19.15 19.25 Welcome and introduction Prof Paul Emery, Chapel Allerton Hospital, Leeds New initiatives to drive Treat to Target Prof Paul Emery, Chapel Allerton Hospital, Leeds Translating clinical targets into realistic personalised goals Prof Peter Taylor, University of Oxford, Oxford TRACK to optimise the consultation process Dr Andrew Östör, Addenbrooke’s Hospital, Cambridge and Kate Gadsby, Rheumatology Nurse Specialist, Derbyshire Royal Infirmary, Derby Question and answer session All speakers (facilitated by Prof Paul Emery) Thank you and close Prof Paul Emery, Chapel Allerton Hospital, Leeds Roche Assessing the evidence: the role of RoACTEMRA in the first-line treatment of rheumatoid arthritis Chair: Prof Ernest Choy, Cardiff University, Cardiff Welcome and introduction Prof Ernest Choy, Cardiff University, Cardiff Presenting the case: First-line use of Tocilizumab in rheumatoid arthritis – flawed or flawless? Prof Ernest Choy, Cardiff University, Cardiff Assessing the evidence: ‘Putting infections into perspective’ Prof John Isaacs, Newcastle University, Newcastle upon Tyne Assessing the evidence: Cardiovascular risk and inflammatory lipids Dr Naveed Sattar, University of Glasgow, Glasgow Assessing the evidence: Neutrophil function in the inflammatory response, platelets and haematology Haematologist speaker Question and answers Faculty 20.00 - Late Conference dinner and Ceilidh Join us for our networking dinner. Enjoy an unforgettable evening of traditional food, drink and entertainment at Òran Mór, which appropriately means the ‘great melody of life’ The evening will begin at 20.00 and tickets are only £40 (Inc VAT). Book early to avoid disappointment Register now! www.rheumatology.org.uk/conference | 25 Thursday 3 May 2012 Science | Trainee | Auto immune diseases | BHPR | Oral abstracts | Special interest group 07.30 - 09.00 Industry supported symposium: Abbott Abbott Axial SpA symposium Axial spondyloarthritis – augmenting diagnosis, management, and treatment Chair: to be confirmed 07.30 07.40 08.00 08.20 08.40 08.55 07.30 - 09.00 Aim: Outcome 1: Outcome 2: Outcome 3: 07.30 07.45 08.00 08.15 08.30 08.45 Welcome and Introduction Session chair Axial spondyloarthritis: distinguishing a presentation Dr Helena Marzo Ortega, Leeds Musculoskeletal Biomedical Research Unit, Leeds Improving diagnosis and management with MRI Dr Alex Bennett, Defence Medical Rehabilitation Centre, Epsom Treatment success in axial spondyloarthritis: ABILITY 1 results Speaker to be confirmed Question and answer Panel Summary and close Session chair SIG: Myositis To provide an update on pertinent issues in myositis and upcoming research/clinical activities To discuss the latest investigations used in the diagnosis and differential diagnosis of myositis To discuss current controversies in the management of inflammatory myositis To gain an understanding of the research topics undertaken through UKMYONET Update on Arthritis Research UK Clinical Studies Group involvement in CTDs Professor David Isenberg, UCL, London Update on antibody testing in inflammatory myopathy Prof Neil McHugh, Royal National Hospital for Rheumatic Disease, Bath Dr Harsha Gunawardena, North Bristol NHS Trust, Bristol Standardisation of histopathological testing in myositis Dr Patrick Gordon, King’s College Hospital, London Treatment issues in myositis: case presentations and discussion Dr Chris Edwards, Southampton University Hospitals NHS Trust, Southampton Genome wide association studies in inflammatory myopathy and UK MYONET genetic study Prof Robert Cooper, Salford Royal NHS Foundation Trust, Salford Discussion Event update | 26 Thursday 3 May 2012 Science | Trainee | Auto immune diseases | BHPR | Oral abstracts | Special interest group 09.00 - 10.30 Aim: Outcome 1: Outcome 2: 09.00 09.10 09.30 09.50 10.10 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.25 09.50 10.15 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.25 09.50 10.15 Molecular mechanisms of disease: osteoarthritis To give attendees an overview and understanding of key issues in the molecular mechanisms of osteoarthritis Delegates will be aware of current dogma of molecular pathogenesis in osteoarthritis Delegates will be aware of novel laboratory research in osteoarthritis Keynote talk on osteoarthritis Dr Tonia Vincent, Imperial College London, London Identification of novel osteoarthritis genes using Zebrafish Dr Chrissy Hammond, University of Bristol, Bristol Is adrenomedullin a potential therapeutic for osteoarthritis while its truncated peptide 22-52 acts as a pro degenerative factor? Dr Frédéric Velard, Lariboisière Hospital, Paris, France Investigation of the role of UFM1 specific peptidase 2 in Beukes hip dysplasia Mr Michal Dudek, University of Manchester, Manchester Cannabidiol blocks the inhibitory effects of the GPR55 agonist L-alpha-lysophosphatidylinositol on mechanosensitive knee joint afferents Mr Kenneth Paton, University of Nottingham, Nottingham Optimising therapy for rheumatoid arthritis Chairs: Dr Maya Buch, University of Leeds, Leeds | Prof Michael Ehrenstein, UCL, London Provide an update on new therapies in RA and how to more effectively use existing therapies to achieve remission Understand the principles of treat to target in RA Appreciate how new therapies will fit into the current treatment pathway for RA Update on the challenges and treatment of extrarticular manifestations of RA Achieving tight control in RA Prof Ronald Van Vollenhoven, Karolinska University Hospital, Stockholm, Sweden New therapies for RA: is there room? Dr Maya Buch, University of Leeds, Leeds Extra-articular complications in RA: impact of biologic therapies and unmet patient need Prof Ian Bruce, University of Manchester, Manchester Panel discussion Pain and motor function: mechanisms and treatment approaches Chairs: Prof Mike Hurley, St George’s University of London, London | Dr Jane Hall, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust To explain how pain interacts at the cortical and peripheral level with the sensorimotor system and how therapies can be targeted to improve musculoskeletal pain using osteoarthritis as a model Delegates will have a greater understanding of how chronic musculoskeletal pain interacts and changes peripheral and central motor control systems They will understand how these changes in function can be identified and explored in the clinical research setting Delegates will have a greater understanding of how therapies can be designed to reduce pain and improve function in the community setting Keeping control of function in the presence of pain: how does the brain cope? Prof Candy McCabe, Royal National Hospital for Rheumatic Diseases, Bath and University of the West of England, Bath Changes in sensorimotor behavior with pain and how to capture these in a movement analysis laboratory Prof Charlotte Hager, Umeå University, Umeå, Sweden Developing effective and affordable community based interventions to improve osteoarthritic pain and function Dr Nicola Walsh, University of the West of England, Bristol Discussion Register now! www.rheumatology.org.uk/conference | 27 09.00 - 10.30 Aim: Outcome 1: Outcome 2: 09.00 09:45 09.00 - 10.30 9.00 9.15 9.30 9.45 10.00 10.15 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.20 09.40 10.00 10.20 Interactive quiz and clinical teaching Chairs: Dr Ben Parker, University of Manchester, Manchester | Dr Sonia Panchal, University Hospital of Leicester NHS Trust, Leicester To review and update clinical teaching of spondyloarthropathies using interactive voting pads to encourage participation To review the spondyloarthropathies To update clinical teaching Psoriatic arthritis Dr Philip Helliwell, University of Leeds, Leeds Ankylosing spondylitis Dr Andrew Keat, Northwick Park Hospital, Harrow Oral abstracts: Epidemiology and Outcomes The risk of solid cancer in patients receiving anti-tumour necrosis factor therapy for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register Dr Louise Mercer, The University of Manchester, Manchester Systemic rheumatoid vasculitis in the biologic era Dr Eleana Ntatsaki, Norfolk and Norwich University Hospital, Norwich Incidence of rheumatoid arthritis in the UK using the 2010 ACR/EULAR classification criteria; and comparison with estimates using the 1987 ACR criteria Dr Jennifer Humphreys, University of Manchester, Manchester Smoking and rheumatoid factor status in predicting responses to biologics Dr Abdul Khan, King’s College Hospital, London Breast is best. Lifecourse influences on the development of knee osteophytes: the Newcastle thousand families study Dr Ajay Abrah, Newcastle University, Prenton Association of systemic sclerosis with different autoantibody subgroups and malignancies: a retrospective registry-based UK cohort study Dr Pia Moinzadeh, Royal Free Hospital, London SIG: Sjögren’s syndrome To review recent advances in oral diagnosis and ocular diagnosis, treatment and research in Sjögren’s syndrome. To review current ongoing clinical research in Sjögren’s syndrome and discuss new initiatives Participants will have updated their knowledge on the oral and ocular manifestations of Sjögren’s syndrome Participants will have been brought up to date on current research and current and future treatments Participants will have received an update on the current multicentre studies Sjögren’s: oral perspectives Dr Gill Smith, Department of Oral Medicine at the Dental Hospital, Glasgow Sjögren’s: the ophthalmology perspective Mr Sanjay Mantry and Dr Ramesh Arora, General Hospital, Glasgow Update on TRACTISS Dr Simon Bowman, Queen Elizabeth Medical Centre, Birmingham Update on UKPSSRS and future directions for Sjögren’s research Dr Fai Ng, Newcastle University, Newcastle Panel discussion Event update | 28 Thursday 3 May 2012 Science | Trainee | Auto immune diseases | BHPR | Oral abstracts | Special interest group 09.00 - 10.30 Aim: Outcome 1: Outcome 2: Outcome 3: 09.00 09.20 09.40 10.00 10.20 10.30 - 11.30 SIG: MSK ultrasound To provide a platform to discuss and share research and training topics to further advance and promote musculoskeletal ultrasound in rheumatology Attendees will learn about new training developments Attendees will be updated in the latest research and direction of ultrasound in rheumatology Attendees will have the opportunity to discuss and share local and national initiatives and projects Musculoskeletal ultrasound in paediatric rheumatology Dr Madeleine Rooney, Musgrave Park Hospital, Belfast Update on the sonoanatomy course David Wright, Sunderland Royal Hospital, Sunderland Training initiatives: The West Midlands experience Dr Rainer Klocke, Dudley Hospitals, Dudley Cutting edge in MUS research Prof Peter Taylor, Imperial College London, London SIG update and a review of BSR courses Dr Cristina Estrach, Aintree University Hospital, Liverpool Poster viewing and exhibition | Tea and coffee Categories: Poster tours: Basic science Basic science Biology of bone, cartilage and connective tissue disease Connective tissue diseases Case reports Cell receptor-ligand interaction, signalling, activation and apoptosis Cytokines and inflammatory mediators Education research Epidemiology Genetics Health services research, economics and outcomes research Rheumatoid arthritis: aetiopathogenesis and animal models Sjögren’s syndrome and other connective tissue disorders SLE and antiphospholipid syndrome Vasculitis 11.30 - 13.00 Advances in psoriatic arthritis Chairs: Prof Costantino Pitzalis, Barts and The London School of Medicine, London | Prof Roger Sturrock, University of Glasgow, Glasgow Aim: Outcome 1: To learn about psoriatic arthritis, from pathogenesis to novel therapies Gain insights on how pathogenesis may contribute to diverse subset evolution both from the joint and skin prospective Understand the issues relating to establishing and running a specialist PsA clinic Be informed on the latest therapeutic strategies to treat PsA Outcome 2: Outcome 3: 11.30 11.50 12.10 12.30 Advances in pathogenesis: the rheumatology view - what biological processes drive different disease expressions in PsA? Prof Costantino Pitzalis, Barts and The London School of Medicine, London Advances in pathogenesis: the dermatology view Prof Frank Nestle, St John’s Institute of Dermatology, London Establishing a specialist PsA clinic: pitfalls and opportunities to improve patient care Prof Neil McHugh, University of Bath, Bath Advances in the treatment of PsA Dr Philip Helliwell, University of Leeds, Leeds Register now! www.rheumatology.org.uk/conference | 29 11.30 - 13.00 Aim: Outcome 1: Outcome 2: 11.30 11.30 - 13.00 Aim: Outcome 1: Outcome 2: 11.30 11.40 12.00 12.20 12.40 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.50 12.10 12:30 Ask the experts: Myositis Chairs: Dr Ben Parker, University of Manchester, Manchester | Dr Sonia Panchal, University Hospital of Leicester NHS Trust, Leicester To discuss the evidence-based approach to myopathies To evaluate complex cases of myopathy with specific reference to the current evidence To discuss complex cases of myopathy Trainees will present three cases to the experts and experts will present two to three slides demonstrating the evidence to support the advice on best practice Dr Hector Chinoy, University of Manchester, Manchester | Prof David Isenberg, UCL, London Molecular mechanisms of disease: inflammatory arthritis I To give attendees an overview and understanding of key issues in the molecular mechanisms of inflammatory arthritis Delegates will be aware of current dogma of molecular pathogenesis in inflammatory arthritis Delegates will be aware of novel laboratory research in inflammatory arthritis Keynote talk on inflammatory arthritis Prof Michael Ehrenstein, UCL, London ANTI-VCA and EBNA1 antibodies are produced in the rheumatoid synovium in the presence of ectopic lymphoid structures and correlates with acpa production Ms Cristina Croia, Queen Mary University of London, London TLR9 induces tolerance to apoptotic cells and is responsible for inducing regulatory B cells Dr Mohini Gray, University of Edinburgh, Edinburgh Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened t- and b- cell responses Dr Gareth Jones, Cardiff University, Cardiff Anti-TNF antibody therapy, but not TNF receptor blockade, induces IL-17 suppressing regulatory T cells Ms Jenny McGovern, University College London, London The management of upper limb dysfunction in people with rheumatoid arthritis Chairs: Ms Jenny Ratcliffe, Macclesfield District General Hospital, Macclesfield | Prof Krysia Dziedzic, Keele University, Keele To provide an update on the evidence based rehabilitation of upper limb dysfunction in people with rheumatoid arthritis (RA) Attendees will gain an understanding of recent advances in the rehabilitation of upper limb dysfunction in RA Attendees will gain an insight into the current surgical management of upper limb dysfunction in RA Attendees will gain an understanding of functional outcome measurement of upper limb dysfunction in RA Current surgical management of the rheumatoid hand and wrist: indications and outcomes Prof Jagdeep Nanchahal, Imperial College London, London Hand and upper limb function assessment in rheumatoid arthritis Mrs Catherine Ball, Imperial College London, London Exercise therapy in the management of upper limb dysfunction in rheumatoid arthritis: results from a randomised controlled trial Dr Lindsay Bearne, King’s College London, London The role of upper limb splinting in the management of people with rheumatoid arthritis Dr Jo Adams, University of Southampton, Southampton Event update | 30 Thursday 3 May 2012 Science | Trainee | Auto immune diseases | BHPR | Oral abstracts | Special interest group 11.30 - 13.00 11.30 11.45 12.00 12.15 12.30 12.45 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.30 - 13.00 Aim: Outcome 1: Outcome 2: Outcome 3: 11.30 11.45 12.00 12.15 12.30 12.45 Oral abstracts: Education NRAS workwise workshops online resources: tools for people with RA to help them remain in the workplace/get back to work Mrs Clare Jacklin, National Rheumatoid Arthritis Society, Maidenhead Designing virtual patients for musculoskeletal education: a grounded theory qualitative study Dr Jes Bateman, University Hospitals Coventry and Warwickshire NHS Trust, Coventry Have you been to Capri? www.capri.scot.nhs.uk early results of a clinic for arthritis patients in remission on the internet Dr Helen Harris, NHS Fife, Kirkcaldy The evaluation of an arthritis education outreach programme to black and minority ethnic communities Mrs Chandrika Gordhan, University of Birmingham, Birmingham Patient experiences, attitudes and expectations towards receiving information about anti-TNF: a qualitative study Dr Paul Arkell, Keele University, Keele National Rheumatoid Arthritis Society survey: impact of RA on the fily Mrs Clare Jacklin, National Rheumatoid Arthritis Society, Maidenhead SIG: Osteoporosis To discuss the management of acute and chronic vertebral fractures for allied health professionals To increase knowledge for allied health care professionals, especially nurses, physiotherapist and occupational therapists of acute vertebral fracture management. Focusing on pain relief and conservative methods of pain relief To increase knowledge and awareness of management of chronic vertebral fracture and further fracture prevention. Suitable for all allied health professionals including dietician, pharmacists, podiatrists etc To discuss the role of allied health care professionals within various fracture liason service models, vertebral pain mangement and prevention of further fracture The management of pain and chronic vertebral fracture and role within fracture liaison service Cathy Churchman, Weston General Hospital, Weston-super-Mare Rachel Lewis MCSP, North Bristol NHS Trust, Bristol SIG: Foot and ankle To provide an update on current developments in the foot and ankle with an emphasis on degenerative disorders To set out the current areas of research activity in foot and ankle research relating to OA To provide a state of the art review of current knowledge To provide a forum to identify future research directions and explore collaborations Researching foot osteoarthritis in primary care Dr Edward Roddy, Keele University Foot outcomes from the Chingford cohort study of 1,000 women over 22 years Dr Catherine Bowen, University of Southampton Foot modeling in degenerative disease and its effect on biomechanical response to interventions Dr Richard Jones, University of Salford Modeling function in barefoot and shod conditions Dr Jill Halstead, University of Leeds Clinical and biomechanical foot assessments and knee OA in the COASt (Clinical Outcomes in knee arthroplasty) study Ms Lucy Gates, University of Southampton Discussion Register now! www.rheumatology.org.uk/conference | 31 13.00 - 14.00 Exhibition | Lunch 13.00 - 14.00 RATS AGM 13.00 - 14.00 NICE and NHS Evidence and the information revolution Aim: Outcome 1: Outcome 2: Outcome 3: Outcome 4: 13.00 14.00 - 15.30 Aim: Outcome 1: 14.00 14.45 14.00 - 15.30 Aim: Outcome 1: Outcome 2: Outcome 3: 14.00 14.20 14.40 15.00 14.00 - 15.30 Aim: Outcome 1: Outcome 2: To demonstrate the key features of NHS Evidence and lead a discussion around further development opportunities for the service Delegates will be able to see how features of the site work and identify what will be useful to them Delegates will be able to discuss any future ideas/developments that could be made around their needs Delegates will learn about the practical QIPP examples that are available and learn how to submit their own case studies Delegates will have more confidence in using the resource in their work around decision-making processes Presentation and discussion facilitation NICE speaker, Manchester Rheumatology and the NHS Chairs: Dr Ben Parker, University of Manchester, Manchester | Dr Sonia Panchal, University Hospital of Leicester NHS Trust, Leicester To update trainees on political changes in the NHS To review the NHS changes as they affect rheumatology and trainees, from both primary and secondary care perspectives A year in politics: an update on political influences on rheumatology and its trainees Dr Chris Deighton, Derbyshire Royal Infirmary, Derby Changes in the NHS: a rheumatology provider’s perspective Dr Alan Nye, Pennine MSK Partnership, Manchester Improving work participation: new developments in reducing work absence for people with musculoskeletal conditions Chairs: Dr Ross Wilkie, Keele University, Keele | Mrs Victoria Chamberlain, Trafford Healthcare Trust, Manchester To provide delegates with an overview of recent advances in approaches and future plans to reduce work absence for people with musculoskeletal conditions Attendees have a clear understanding of the importance of supporting people with arthritis / MSDs in remaining and returning to work, and of the role of health professionals in this Attendees learn about practical tools (e.g. the fit-note) and examples of best practice in supporting people with arthritis / MSDs in remaining and returning to work Attendees are aware of further developments in policy and practice to reduce work absence What is next for musculoskeletal conditions and work? Prof Dame Carol Black, Department for Work and Pensions, London What has the “fit-note” done for us? Reflections on the impact on work absence and disability Dr Bill Gunneyon, Department for Work and Pensions, London Rheumatology and work: evolving practice Dr David Walker, Freeman Hospital, Newcastle upon Tyne Reducing work absence for people with musculoskeletal conditions: the barriers that stop me working! Ms Rosemarie Buttery, Arthritis Care, London Molecular mechanisms of disease: inflammatory arthritis II To give attendees an overview and understanding of key issues in the molecular mechanisms of inflammatory arthritis Delegates will be aware of current dogma of molecular pathogenesis in inflammatory arthritis Delegates will be aware of novel laboratory research in inflammatory arthritis Event update | 32 Thursday 3 May 2012 Science | Trainee | Auto immune diseases | BHPR | Oral abstracts | Special interest group 14.00 14.15 14.30 14.45 15.00 15.15 14.00 - 15.30 Aim: Outcome 1: Outcome 2: Outcome 3: 14.00 14:25 14:50 14.00 - 15.30 14.00 14.15 14:30 14:45 15:00 15:15 Inhibition of NAMPT (PBEF/Visfatin) decreases the ability of human neutrophils to generate reactive oxidants, but does not impair bacterial killing Ms Kate Roberts, University of Liverpool, Liverpool Neutrophil microparticles as potential novel effectors of joint disease Ms Sarah Headland, Barts and the London School of Medicine and Dentistry, London The mesenchymal stromal cell marker CD248 regulates inflammatory arthritis and bone formation Dr Amy Naylor, University of Birmingham, Birmingham Resolvin D1 limits PMN recruitment to inflammatory loci: receptor dependent bioactions Dr Lucy Norling, Barts and The London Medical School, London Dual specificity phosphatase 1 is a crucial negative regulator of inflammatory osteolysis and a mediator of therapeutic effects of dexamethasone in collagen-induced arthritis Ms Youridies Vattakuzhi, Kenndy Institute of Rheumatology, London The regulation of arthritic bone erosions by IL-10 Dr Claire Greenhill, Cardiff University, Cardiff What’s new in ankylosing spondylitis pathogenesis, assessment and treatment Chairs: Prof Paul Bowness, Nuffield Orthopaedic Centre NHS Trust, Oxford | Dr Jonathan Packham, University Hospital of North Staffordshire, Stoke on Trent To give attendees an overview of new developments in the genetics, pathogenesis and treatment of ankylosing spondylitis Delegates will be aware the genetic contribution and pathogenic theories of ankylosing spondylitis pathogenesis Delegates will be able to describe the new ASA criteria for Axial SpA and the ASDAS Delegates will be able to describe the critically evaluate the efficacies of new treatments for ankylosing spondylitis Overview of ankylosing spondylitis genetics and pathogenesis Prof Paul Bowness, Nuffield Orthopaedic Centre NHS Trust, Oxford What’s new in the clinical assessment of AS? Prof Désirée van der Heijde, Leiden University Medical Center, Leiden, The Netherlands New therapies for ankylosing spondylitis, targeting the Th17 pathway? Prof Dominique Baeten, University of Amsterdam, Amsterdam, The Netherlands Oral abstracts: Genetics Global gene expression analysis of dedifferentiated chondrocytes Mr Alan Mueller, University of Liverpool, Liverpool Largest UK rheumatoid arthritis genome wide association study to date of 8,300 samples strengthens confirmed loci and highlights more potential RA genetic risk factors Dr Gisela Orozco, University of Manchester, Manchester Fine mapping in over 14,000 rheumatoid arthritis cases and 18,500 controls refine associations to known loci, indicate multiple independent affects and reveal novel associations Prof Jane Worthington, The University of Manchester, Manchester Investigation of idiopathic inflammatory myopathy for shared genetic risk factors with other autoimmune disorders Dr Meghna Jani, Salford Royal NHS Foundation Trust, Manchester Analysis of the immunochip in a large cohort of oligo- and polyarthritis juvenile idiopathic arthritis cases confirms previous and identifies novel associations Dr Joanna Cobb, University of Manchester, Manchester Genome-wide association study of methotrexate response identifies novel genes in a large cohort of European juvenile idiopathic arthritis cases Dr Joanna Cobb, University of Manchester, Manchester Register now! www.rheumatology.org.uk/conference | 33 14.00 - 15.30 Aim: Outcome 1: Outcome 2: Outcome 3: 14.00 14.40 15.00 14.00 - 15.30 Aim: Outcome 1: Outcome 2: Outcome 3: 14.00 14.05 14.20 14.40 15.20 15.30 - 17.00 15.30 15.40 16.00 16.20 16.40 17.00 SIG: Education To provide an update on Arthritis Research UK educational developments over the last 12 months Participants will understand (and participate in) the Arthritis Research UK tool for evalution of online learning resources Participants will be informed of the results of a study of CPD activities among rheumatology nurses and allied health professionals The opportunity for participants to discuss work in progress: educational developments or research Development of a tool to evaluate online learning resources in rheumatology Dr David Walker, Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne and Dr Tom Margham, Arthritis Research UK Results of a survey of rheumatology nurses and allied health professionals regarding CPD activities: the service constraints of NHS practice? Dr Sarah Ryan, Dept of Rheumatology, Haywood Hospital, Stoke-on-Trent Open forum of educational developments Prof Andrew Hassell, Keele University School of Medicine and Haywood Hospital, Keele SIG: Osteoarthritis To reflect on achievements of the OA CSG over the first four years and learn from other CSGs in shaping future strategy Know the strategy, submission and review processes of the Arthritis Research UK OA Clinical Studies Group Learn how to become involved in ongoing studies Have had the opportunity to network with other researchers and discuss research ideas Introduction and welcome Dr Fraser Birrell, Newcastle University, Newcastle upon Tyne Progress of the Inflammatory Arthritis CSG Prof John Isaacs, Newcastle University, Newcastle upon Tyne Clinical Studies Group for OA and Related Disorders strategy Prof Philip Conaghan, University of Leeds, Leeds Translating ideas into action and results: group work Hand OA Facilitator: Dr Krysia Dziedzic, Keele University, Keele Knee OA Facilitator: Dr George Peat, Keele University, Keele Hip OA Facilitator: to be confirmed Question and answer SIG: Spondyloarthropathy Welcome and Introduction Prof Dennis McGonagle, University of Leeds, Leeds and Dr Raj Sengupta, The Royal National Hospital for Rheumatic Diseases, Bath Quality indicators for SpA in the UK Pitfalls with diagnosis in spinal MRI scans Dr Alex Bennett, Guys and St Thomas’ Teaching Hospitals, London, IL12/23 p40 monoclonal antibody therapy in psoriatic disease: where are we? Speaker to be confirmed The transition between psoriasis and arthritis: an imaging perspective Speaker to be confirmed End of meeting Event update | 34 Conference registration Please note all prices shown include VAT Delegate type One day Two day Whole conference *Early Late *Early Late *Early Late BSR Member £102.00 £147.90 £204.00 £295.80 £260.10 £377.15 BSR RATS £71.40 £103.53 £142.80 £207.06 £182.07 £264.00 BSR non member £147.90 £214.46 £295.80 £428.91 £377.15 £546.86 BHPR Member £60.00 £87.00 £120.00 £174.00 £153.00 £221.85 BHPR non member £87.00 £126.15 £174.00 £252.30 £198.90 £288.41 **Reduced BSR Member £61.20 £88.74 £122.40 £177.48 £156.06 £226.29 **Non-clinical scientists/Students £42.00 £42.00 £84.00 £84.00 £126.00 £126.00 ARMA £42.00 £42.00 £84.00 £84.00 £126.00 £126.00 * Any registrations received on or before the early bird deadline – Friday 3 February 2012 – will be processed at the early rate. ** To see how to qualify for this rate, please visit the website www.rheumatology.org.uk/registration Registration package Registration includes: Entry to the scientific sessions of your choice on the days for which you have registered Entry to the Exhibition Delegate bag with conference programme and abstracts Lunch and refreshments Welcome reception (for those registered for Tuesday and/or Wednesday) Register online now Registering for Rheumatology 2012 is easy. Simply visit www.rheumatology.org.uk/conference to book your place at the UK’s leading rheumatology event. If you wish to pay for your registration via invoice, you can request an invoice online. Please note that all registration fees must be paid in full before we can issue you with your delegate badge. Online registration closes at 17.00 on Friday 27 April 2012. On-site registration If there are places available, you can register for the conference on-site. Please note that registration rates will be higher on-site as they will include an additional admin fee. We are not able to issue invoices on-site. Why not save money, avoid the queues at registration and guarantee your place by booking online now at www.rheumatology.org.uk/conference Cancellation and amendments If you cancel in writing on or before 30 March 2012 you will receive a refund minus an admin fee of £20. No fees will be refunded for any cancellations received after 30 March 2012 under any circumstances. Name change amendments are accepted at our discretion and carry a £20 admin fee. Please see our website for full terms and conditions. Register now! www.rheumatology.org.uk/conference | 35 Exhibition It is with great pleasure we announce Rheumatology 2012’s exhibition, which will run alongside the conference, attracting leading industry partners in the field of rheumatology. We expect a number of companies specialising in biologic drugs, medical clinic software, diagnostic tools, ultrasound machines, medical therapies, biotechnology and therapeutic products alongside principal patient charities, educational providers and publishers. The exhibition takes place in Hall 5 at the SECC where you can meet with your industry colleagues and learn directly about their products and services. You are invited to visit the exhibition at the following times: Tuesday 01 May 2012 Wednesday 02 May 2012 Thursday 03 May 2012 09.00-17.00 09.00-17.00 09.00-14.15 Industry supported sympoisa Rheumatology 2012 will once again host the popular industry supported symposia. These educational sessions, scheduled during the conference, are free of charge, allow you the opportunity to listen to exciting topics, experience innovative formats and network. Sessions will be hosted within the SECC, with a maximum of two symposia running concurrently on the following dates: Pfizer Tuesday 01 May | 18.00-19.30 Bristol Myers Squibb Wednesday 02 May | 07.30-09.00 Cellestis GmbH Wednesday 02 May | 07.30-09.00 Abbott Wednesday 02 May | 18.00-19.30 Roche Wednesday 02 May | 18.00-19.30 Abbott Thursday 03 May | 07.30-09.00 Please visit www.rheumatology.org.uk/conference for further details. Exhibitors currently confirmed: A. Algeo ARMA Arthritis Care Arthritis Research UK 4S Information Systems Abbott BARC British Health Professionals in Rheumatology Bristol Myers Squibb British Society for Rheumatology BSR Biologics Register BSSA Central Homecare Eli Lilly Fibromyalgia Association GlaxoSmithKline Grunenthal Healthcare at Home Lupus UK Medac UK Merck Sharpe and Dohme Miltenyi Biotec Ltd NASS NRAS Oxford University Press Oxford Diagnostic Laboratories PMR & GCA Pfizer PSALV Pulmonary Hypertension Association UK RCN Roche Products Ltd Scleroderma Society Servier Lab Ltd UCB Wisepress ‘Networking with colleagues in rheumatology is invaluable and the conference is the perfect opportunity to do just that’ Delegate You have told us that networking can be one of the most valuable activities at the conference. We have some great networking opportunities to ensure you get the most from your conference experience Tuesday 1 May, 19.45-21.00 President’s reception The Presidents of BSR and BHPR invite you to join them and your fellow delegates to continue your discussions from the day, catch up with colleagues and make new contacts at this informal social event. This event will take place at the adjacent Crowne Plaza Hotel Drinks and canapés will be provided at this excellent networking platform The event is free to attend for registered conference delegates. Wednesday 2 May, 20.00-00.00 Conference dinner and ceilidh Back by popular demand, the conference dinner promises an exceptional evening of traditional Scottish food and dancing. Join us at Òran Mór for networking with colleagues at this entertaining event. 20.00: 20.30: 22.00: 23.00: Drinks reception Dinner Ceilidh Further entertainment Places are limited so be sure to book early. Tickets are only £40 (Inc VAT) BSR, Bride House, 18-20 Bride Lane, London EC4Y 8EE Tel: +44 (0) 20 7842 0900 Fax: +44 (0) 20 7842 0901 Website: www.rheumatology.org.uk A Charity registered in England and Wales A Company limited by guarantee VAT No: 404 5637 66 Company Reg. No: 3470316 Charity No: 1067124 ® MIX From responsible sources FSC® TT-COC-002846 www.fsc.org